「Debut Biotechnology」宣布公司在B轮融资中获得3400万美元融资,以用于业务范围的扩大。该轮融资由BOLD领投,Fine Structure Ventures、Material Impact、GS Futures、Cavallo Ventures、Cultivian Sandbox Ventures、ACVC Partners等参与。 据悉,Debut Biotechnolog ...
引言免疫治疗最令人着迷的地方,是它并不直接“毒杀”癌细胞,而是试图让免疫系统重新看见肿瘤。但问题也恰在这里:很多肿瘤并非没有抗原,而是把周围微环境改造成了一个免疫低反应区。T细胞进不来,树突状细胞不成熟,抗原呈递不足,检查点抑制剂也常常缺少“可释放的 ...
Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent filings.
引言如果一个基因编辑工具在试管里很强,却在细胞里“站不稳”,它还能走向治疗吗?这正是5月21日发表于 《Nature Biotechnology》 的研究 “AI-guided redesign of laboratory-evolved ...
Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust clinical pipeline.
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...
"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...
Masinde Muliro University of Science and Technology and National Biosafety Authority signs MoU to train students on biotechnology related courses /HANDOUTNationalBiosafety Authority has signed a ...
Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果